InsiderClue
Stocks · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Envoy Medical, Inc.

COCH Clue Score31
United States Fiscal year ends December CIK 0001840877
$0.66 +0.03% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.66 −93.21% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 29 Apr 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Operating income−5.2Net income−0.3Fiscal year 2022Revenue0.2Operating income−8.7Net income−15.9EPS, diluted−1.57Fiscal year 2023Revenue0.3 +33.3%Operating income−18.4Net income−29.9EPS, diluted−2.54Fiscal year 2024Revenue0.2 −28.8%Operating income−19.3Net income−20.8EPS, diluted−1.49Fiscal year 2025Revenue0.2 +7.1%Operating income−22.3Net income−23.8EPS, diluted−1.23
FY2021FY2022FY2023FY2024FY2025
Revenue n/a 0.2 0.3 0.2 0.2
Growth +33.3% −28.8% +7.1%
Operating income −5.2 −8.7 −18.4 −19.3 −22.3
Net income −0.3 −15.9 −29.9 −20.8 −23.8
Growth
EPS, diluted n/a −1.57 −2.54 −1.49 −1.23

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2021Fiscal year 2022Operating margin−3,673.4%Net margin−6,718.6%Free cash flow margin−3,807.2%Fiscal year 2023Operating margin−5,809.8%Net margin−9,469.0%Free cash flow margin−5,457.0%Fiscal year 2024Operating margin−8,558.2%Net margin−9,242.2%Free cash flow margin−8,412.9%Fiscal year 2025Operating margin−9,240.7%Net margin−9,857.3%Free cash flow margin−7,626.6%
FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −3,673.4% −5,809.8% −8,558.2% −9,240.7%
Net margin n/a −6,718.6% −9,469.0% −9,242.2% −9,857.3%
Free cash flow margin n/a −3,807.2% −5,457.0% −8,412.9% −7,626.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−3.2Fiscal year 2022Operating cash flow−8.8Capital expenditure−0.2Free cash flow−9.0Fiscal year 2023Operating cash flow−17.1Capital expenditure−0.2Free cash flow−17.2Fiscal year 2024Operating cash flow−17.9Capital expenditure−1.0Free cash flow−18.9Dividends paid−2.4Fiscal year 2025Operating cash flow−18.2Capital expenditure−0.2Free cash flow−18.4Dividends paid−1.8
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −3.2 −8.8 −17.1 −17.9 −18.2
Capital expenditure n/a −0.2 −0.2 −1.0 −0.2
Free cash flow n/a −9.0 −17.2 −18.9 −18.4
Growth
Dividends paid n/a n/a n/a −2.4 −1.8

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash0.1Shareholders’ equity−45.0Fiscal year 2022Cash0.2Shareholders’ equity−36.2Fiscal year 2023Cash4.2Shareholders’ equity−1.8Fiscal year 2024Cash5.5Shareholders’ equity−18.8Fiscal year 2025Cash3.7Shareholders’ equity−12.2
FY2021FY2022FY2023FY2024FY2025
Cash 0.1 0.2 4.2 5.5 3.7
Shareholders’ equity −45.0 −36.2 −1.8 −18.8 −12.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a −3,673.4% −5,809.8% −8,558.2% −9,240.7%
n/a 8,749.1% n/a −9,242.2% −9,857.3%
n/a −6,718.6% −9,469.0% −9,242.2% −9,857.3%
n/a −3,807.2% −5,457.0% −8,412.9% −7,626.6%
Spending
n/a 2,099.2% 2,834.2% 4,524.0% 5,180.9%
n/a 1,090.7% 2,302.5% 3,033.8% 3,290.9%
n/a 92.0% 48.4% 435.6% 74.3%
n/a 7.2% n/a n/a n/a
Returns
−0.1% −623.0% −361.8% −180.2% −277.6%
Balance and payout
9.0% 1,516.1% 121.5% 263.3% 237.5%